These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38155176)

  • 1. Genome analysis of triple phages that curtails MDR E. coli with ML based host receptor prediction and its evaluation.
    Unnikrishnan VK; Sundaramoorthy NS; Nair VG; Ramaiah KB; Roy JS; Rajendran M; Srinath S; Kumar S; S PS; S SM; Nagarajan S
    Sci Rep; 2023 Dec; 13(1):23040. PubMed ID: 38155176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antibacterial Effects of Cocktail and Single Forms of Lytic Phages Belonging to
    Jokar J; Rahimian N; Ghasemian A; Najafipour S
    Biomed Res Int; 2022; 2022():7833565. PubMed ID: 36467878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
    Ngiam L; Schembri MA; Weynberg K; Guo J
    Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014.
    Villarroel J; Larsen MV; Kilstrup M; Nielsen M
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29099783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential.
    Sada TS; Tessema TS
    BMC Infect Dis; 2024 Mar; 24(1):310. PubMed ID: 38486152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
    Zurabov F; Zhilenkov E
    Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting
    Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R
    Front Microbiol; 2019; 10():574. PubMed ID: 30949158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
    Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
    Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Cocktails Constrain the Growth of
    Wandro S; Ghatbale P; Attai H; Hendrickson C; Samillano C; Suh J; Dunham SJB; Pride DT; Whiteson K
    mSystems; 2022 Aug; 7(4):e0001922. PubMed ID: 35762793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli.
    Pereira C; Moreirinha C; Lewicka M; Almeida P; Clemente C; Romalde JL; Nunes ML; Almeida A
    Virus Res; 2017 Jan; 227():171-182. PubMed ID: 27756632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two Staphylococcus aureus phage cocktails in cheese production.
    El Haddad L; Roy JP; Khalil GE; St-Gelais D; Champagne CP; Labrie S; Moineau S
    Int J Food Microbiol; 2016 Jan; 217():7-13. PubMed ID: 26476571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and evaluation of cocktail phages for the control of multidrug-resistant Escherichia coli serotype O104: H4 and E. coli O157: H7 isolates causing diarrhea.
    Safwat Mohamed D; Farouk Ahmed E; Mohamed Mahmoud A; Abd El-Baky RM; John J
    FEMS Microbiol Lett; 2018 Feb; 365(2):. PubMed ID: 29253127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of effectiveness for phage cocktail development against multiple Salmonella serovars and its biofilm control activity.
    Ribeiro JM; Pereira GN; Durli Junior I; Teixeira GM; Bertozzi MM; Verri WA; Kobayashi RKT; Nakazato G
    Sci Rep; 2023 Aug; 13(1):13054. PubMed ID: 37567926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classifying the Unclassified: A Phage Classification Method.
    Chibani CM; Farr A; Klama S; Dietrich S; Liesegang H
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813498
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.